Target intelligence / Profile preview

SPOPL divergent transcript (SPOPL-DT)

Target
SPOPL-DT
Molecular classification
Long non-coding RNA (lncRNA), Divergent transcript (antisense RNA generated through divergent transcription), Other (if using structured schema for non-target transcripts)
01

Overview

SPOPL divergent transcript (SPOPL-DT) is a long non-coding RNA (lncRNA) located on chromosome 2q22.1, overlapping or adjacent to the SPOPL gene locus. Divergent transcripts are a class of noncoding RNAs generated through transcription starting from gene promoter regions in the opposite orientation to the coding gene, often resulting in short, unstable or regulatory RNAs. While some divergent lncRNAs have regulatory functions, such as modulating chromatin states or influencing the transcription of nearby genes, no specific functional or disease-related role has been defined for SPOPL-DT in the current literature. There are no known drug interactions, therapeutic mechanisms, or established biomarker roles for this transcript. Its inclusion as a drug target is likely inaccurate, as it is not a protein or conventional pharmacological target.

02

Mechanism of action

Not applicable; as it is not a known therapeutic target.

03

Biological functions

No direct biological function has been established for the "SPOPL divergent transcript"Divergent lncRNAs in general may regulate the expression of nearby genes, chromatin states, or broader transcriptional programsRegulation of transcription (by acting at promoter/enhancer regions)Epigenetic modification coordination
04

Disease associations

No established roles for SPOPL divergent transcript in disease.lncRNAs and divergent transcripts can sometimes play regulatory roles in cancer, development, and immune response in some cases, but there is no published evidence for disease involvement of SPOPL divergent transcript itself.

Beyond the preview

Go deeper on SPOPL divergent transcript (SPOPL-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SPOPL divergent transcript (SPOPL-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call